Health & Fitness
Thu, September 6, 2012
FOSTER CITY, Calif.--([ BUSINESS WIRE ])--Gilead Sciences, Inc. (Nasdaq: GILD) today announced that its corporate presentation will be webcast from the Morgan Stanley Global Healthcare Conference in New York.
John F. Milligan, PhD, Gileadas President and Chief Operating Officer, will provide an overview of the company at the Morgan Stanley conference on Wednesday, September 12 at 12:05 p.m. Eastern Time.
To access the live webcast or a replay via the internet log on to [ www.gilead.com ]. Please connect to the companyas website at least 15 minutes prior to the start of the presentation to ensure adequate time for any software download that may be necessary to listen to the webcast. The replay will be available for 14 days following the presentation.
About Gilead
Gilead Sciences is a biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need. The companyas mission is to advance the care of patients suffering from life-threatening diseases worldwide. Headquartered in Foster City, California, Gilead has operations in North America, Europe and Asia Pacific.
For more information on Gilead Sciences, please visit [ www.gilead.com ] or
call the Gilead Public Affairs Department at 1-800-GILEAD-5 (1-800-445-3235).
